Jackson Wealth Management Has Raised Johnson & Johnson (JNJ) Stake; Capital Investment Advisors Boosted Gilead Sciences (GILD) Holding By $431,060

November 14, 2017 - By Vivian Park

Jackson Wealth Management Llc increased Johnson & Johnson (JNJ) stake by 11.38% reported in 2017Q2 SEC filing. Jackson Wealth Management Llc acquired 3,071 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Jackson Wealth Management Llc holds 30,067 shares with $3.98M value, up from 26,996 last quarter. Johnson & Johnson now has $374.74 billion valuation. The stock rose 0.38% or $0.53 reaching $140.02 per share. About 4.07 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since November 14, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Capital Investment Advisors Llc increased Gilead Sciences Inc (GILD) stake by 24.58% reported in 2017Q2 SEC filing. Capital Investment Advisors Llc acquired 6,158 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Capital Investment Advisors Llc holds 31,212 shares with $2.21 million value, up from 25,054 last quarter. Gilead Sciences Inc now has $92.92 billion valuation. The stock rose 0.13% or $0.09 reaching $71.24 per share. About 10.92 million shares traded or 30.94% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since November 14, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences had 106 analyst reports since July 29, 2015 according to SRatingsIntel. On Wednesday, October 4 the stock rating was maintained by Bank of America with “Neutral”. The company was maintained on Wednesday, July 29 by Needham. Bank of America upgraded Gilead Sciences, Inc. (NASDAQ:GILD) rating on Friday, January 15. Bank of America has “Neutral” rating and $107.0 target. Leerink Swann downgraded it to “Mkt Perform” rating and $94 target in Tuesday, September 27 report. Leerink Swann maintained the stock with “Market Perform” rating in Thursday, October 5 report. The firm has “Buy” rating given on Monday, June 12 by Jefferies. The company was maintained on Thursday, September 28 by Mizuho. The rating was maintained by Jefferies with “Buy” on Tuesday, October 25. The rating was downgraded by Needham on Tuesday, July 26 to “Hold”. The firm has “Buy” rating given on Tuesday, November 8 by Mizuho.

Capital Investment Advisors Llc decreased Sector Spdr Util Select (XLU) stake by 25,966 shares to 168,764 valued at $8.77M in 2017Q2. It also reduced Cohen & Steers Ltd Duration Pf (LDP) stake by 22,523 shares and now owns 46,323 shares. Peoples United Finl Inc (NASDAQ:PBCT) was reduced too.

Investors sentiment increased to 0.93 in 2017 Q2. Its up 0.02, from 0.91 in 2017Q1. It is positive, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Renaissance Ltd holds 0.94% or 10.41M shares. Capital Impact Advsr Limited Liability Company stated it has 0.48% in Gilead Sciences, Inc. (NASDAQ:GILD). Gabelli Funds Limited Liability Corp, a New York-based fund reported 76,500 shares. Raymond James And has 0.14% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Stanley invested 0.76% in Gilead Sciences, Inc. (NASDAQ:GILD). Private Advisor Grp Inc Limited Liability Company holds 0.15% or 80,809 shares in its portfolio. Meritage Portfolio has invested 0.08% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Capstone Llc stated it has 0.04% in Gilead Sciences, Inc. (NASDAQ:GILD). Fayerweather Charles holds 1.21% or 12,717 shares. Smith Chas P And Assoc Pa Cpas reported 0.03% stake. The Delaware-based Reliance Of Delaware has invested 0.08% in Gilead Sciences, Inc. (NASDAQ:GILD). The Missouri-based Shelter Ins Retirement Plan has invested 1.5% in Gilead Sciences, Inc. (NASDAQ:GILD). Campbell & Investment Adviser Limited Liability Corp invested in 4,374 shares. Barclays Plc holds 0.4% or 5.24M shares in its portfolio. Price T Rowe Incorporated Md reported 14.98M shares or 0.19% of all its holdings.

Since June 1, 2017, it had 0 insider buys, and 2 selling transactions for $5.11 million activity. $4.78M worth of stock was sold by MARTIN JOHN C on Thursday, June 1. Shares for $325,114 were sold by Alton Gregg H.

Investors sentiment decreased to 0.83 in 2017 Q2. Its down 0.03, from 0.86 in 2017Q1. It turned negative, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. 1.73 billion shares or 0.03% less from 1.73 billion shares in 2017Q1 were reported. Kidder Stephen W has invested 5.45% in Johnson & Johnson (NYSE:JNJ). Adirondack Company holds 3.43% or 32,203 shares in its portfolio. Winfield Associates Inc invested in 0.4% or 5,477 shares. Sterneck Capital Management Ltd Limited Liability Company owns 1,668 shares. Swedbank reported 3.06% stake. Rmb Capital Mngmt Llc invested 0.16% in Johnson & Johnson (NYSE:JNJ). Stonebridge Advsr Ltd Liability Com holds 1.8% or 51,830 shares. Asset Of Georgia Incorporated Ga Adv stated it has 1.31% of its portfolio in Johnson & Johnson (NYSE:JNJ). Bluecrest Capital Mngmt Ltd reported 16,678 shares. Moreover, Greenleaf has 0.15% invested in Johnson & Johnson (NYSE:JNJ). Massachusetts-based S&Co has invested 3.74% in Johnson & Johnson (NYSE:JNJ). Roberts Glore Comm Inc Il, Illinois-based fund reported 54,779 shares. 180,339 are held by Van Eck Assocs Corp. Parametric Port Assoc Ltd Company invested in 1.3% or 7.97 million shares. Texas-based Oxbow Advisors Ltd Liability Com has invested 0.84% in Johnson & Johnson (NYSE:JNJ).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com